Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Mictoryl, Mictoryl Pediatric
Synonyms :
propiverine
Class :
Anticholinergic Agent
Dosage Forms & StrengthsÂ
Capsule (Extended Release)Â
30 mgÂ
45 mgÂ
TabletÂ
5 mgÂ
Take an initial dose of 30 mg one time a day and it may raise up to 45 mg one time a day
Dosage Forms & StrengthsÂ
Tablet Â
5 mgÂ
for Children and Adolescents:
Take a daily dose of 0.8 mg/kg orally in 2 divided doses
Dose of 5 mg two twice a day for 12 to 16 kg
Dose of 5 mg in the morning and 10 mg in the evening for 17 to 22 kg
Dose of 10 mg twice a day for 23 to 28 kg
Dose of 10 mg in the morning and 15 mg in the evening for 29 to 34 kg
Dose of 15 mg twice a day for ≥35 kg
Refer to adult dosingÂ
Actions and SpectrumÂ
The action of propiverine involves its effect on the muscarinic receptors found in the bladder smooth muscle and other tissues. Â
By blocking these receptors, it reduces the involuntary contractions of the bladder, thereby increasing the bladder’s capacity.
Frequency not defined Â
Edema Â
Hypertension Â
Fatigue Â
Urinary incontinenceÂ
Hypotension Â
Bradycardia, chest pain Â
Dizziness, fatigue, headache Â
PalpitationÂ
Sore throatÂ
Dysuria Â
Abdominal distensionÂ
Urinary retentionÂ
Intestinal obstructionÂ
Atrioventricular block Â
Confusion Â
Delirium, hallucinationÂ
Drowsiness, excitability Â
Insomnia, paralysis Â
Pruritus, skin rashÂ
Impaired consciousness, restlessnessÂ
Abdominal painÂ
Constipation, dyspepsia Â
Urticaria, erythemaÂ
PolydipsiaÂ
Myoglobin increased, thrombocytopeniaÂ
HypersensitivityÂ
Back pain, dyskinesiaÂ
Diarrhea, nauseaÂ
LeukopeniaÂ
Increased creatine phosphokinaseÂ
Myalgia Â
RhabdomyolysisÂ
Eye pain Â
GlaucomaÂ
Increased intraocular pressureÂ
Increased blood urea nitrogen Â
Oculomotor disturbance Â
Accommodation disturbancesÂ
Increased creatinine clearance Â
Post marketing reports Â
CoughÂ
TinnitusÂ
Renal insufficiencyÂ
Upper respiratory tract infectionÂ
Fever Â
LeukocytosisÂ
PainÂ
Increased bronchial secretions Â
DyschromiaÂ
Black Box WarningÂ
None
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
propiverine has an antispasmodic action on bladder smooth muscle by blocking calcium influx and modifying intracellular calcium. Â
It also has anticholinergic activity, which leads to a decrease in intravesical pressure.Â
PharmacodynamicsÂ
propiverine is a competitive antagonist of muscarinic receptors, particularly the M1, M2, and M3 subtypes. Â
These receptors are G-protein-coupled receptors that mediate the effects of acetylcholine, a neurotransmitter released by cholinergic nerve endings. Â
PharmacokineticsÂ
Absorption  Â
propiverine is rapidly absorbed from the gastrointestinal tract.Â
DistributionÂ
propiverine is distributed throughout the body via bloodstream.Â
MetabolismÂ
propiverine undergoes extensive first-pass metabolism in the liver.Â
Elimination and excretionÂ
propiverine are excreted primarily through the urine.Â
AdministrationÂ
propiverine is orally administered, usually in the form of tablets or extended-release capsules.Â
Patient information leafletÂ
Generic Name: propiverineÂ
Why do we use propiverine?Â
propiverine is indicated for the relief of urinary symptoms including sudden, strong need to urinate. Â
propiverine is primarily used for the treatment of overactive bladder (OAB) symptoms, which include urgency, frequency, and urge incontinence. Â